Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1

April 11, 2022 updated by: Virginia Commonwealth University

Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals: The Impact of Cardiovascular Fitness and Acute Aerobic Exercise - Study 1

The purpose of this research study is to examine the effect of high-fat meals on the health of blood vessels. In addition, the study will examine how exercise/fitness/physical activity impacts blood vessels after consumption of a high-fat meal.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This is the first in a series of studies examining the impact of high-fat meals on blood vessels. During the preliminary visit of this study, eligible participants' resting metabolic rate, arm flow mediated dilation, and leg flow mediate dilation will be measured. They will complete handgrip and plantar flexion exercise tasks. Finally, they will be given a physical activity monitor to wear for 7 days. At their first visit, participants will eat a high-fat meal and blood will be drawn to measure blood vessel health. They will also repeat the arm flow mediated dilation, leg flow mediate dilation, handgrip, and plantar flexion exercise tests.

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Richmond, Virginia, United States, 23298
        • Virginia Commonwealth University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. college-age: 18-30 years old
  2. normal fasting triglyceride (<150 mg/dL) (American College of Sports Medicine Guidelines for Exercise Testing and Prescription, 10th Edition).
  3. normal body composition: % body fat, males <25%, females <32% (American College of Sports Medicine Guidelines for Exercise Testing and Prescription, 10th Edition)
  4. self-reported engagement in moderate-vigorous intensity physical activity and/or an exercise training regimen OR self-reported low physical activity and no engagement in an exercise training regimen (International Physical Activity Questionnaire)
  5. low cardiorespiratory fitness (VO2peak; male: =<45 mL/kg/min; female: =<35 mL/kg/min; categorized as =40th percentile by ACSM Guidelines for Exercise Testing and Prescription, 10th Edition; 44, 45, 46, 47) OR high cardiorespiratory fitness (VO2peak; male: =55 mL/kg/min; female: 45 mL/kg/min; categorized as =70th percentile by ACSM Guidelines for Exercise Testing and Prescription, 10th Edition; 44, 45, 46, 47)

f.) for female participants, presence of a normal, monthly menstrual cycle with or without prescribed contraceptive methods.

.

Exclusion Criteria:

  1. presence of diagnosed cardiovascular, metabolic, or renal disease or dysfunction
  2. presence of signs and symptoms suggestive of cardiovascular, metabolic, or renal disease
  3. presence of musculoskeletal injury
  4. pregnancy
  5. history of smoking
  6. engagement in an abnormal eating behavior
  7. unable to communicate effectively in English
  8. moderate cardiorespiratory fitness (VO2peak; male: 46-54 mL/kg/min; female: 36-44 mL/kg/min)
  9. elevated or high fasting triglycerides (>150 mg/dL)
  10. absence of a normal, monthly menstrual cycle with or without prescribed contraceptive methods

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Low physical activity/fitness
Participants will be classified as into low-physical fitness based on self-reported physical activity and cardiorespiratory fitness testing.
Participants will be given a serving of Marie Callendar's Chocolate Satin Pie to eat over a period of 20 minutes
OTHER: High physical activity/fitness
Participants will be classified as into high-physical fitness based on self-reported physical activity and cardiorespiratory fitness testing.
Participants will be given a serving of Marie Callendar's Chocolate Satin Pie to eat over a period of 20 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fasting triglycerides
Time Frame: Baseline
Ester derived from glycerol and three fatty acids, representative of the main constituent of body fat in humans.
Baseline
Post HFM Triglycerides
Time Frame: 4 hours
Ester derived from glycerol and three fatty acids, representative of the main constituent of body fat in humans.
4 hours
Fasting total cholesterol
Time Frame: Baseline
Type of lipid that is required for cell structure, but can contribute to increased risk of heart disease if high due to development of fatty deposits on vascular wall.
Baseline
Post HFM total cholesterol
Time Frame: 4 hours
Type of lipid that is required for cell structure, but can contribute to increased risk of heart disease if high due to development of fatty deposits on vascular wall.
4 hours
Fasting LDL
Time Frame: Baseline
Low density lipoprotein that transports fat molecules in the body. Associated with high levels of cholesterol.
Baseline
Post HFM LDL
Time Frame: 4 hours
Low density lipoprotein that transports fat molecules in the body. Associated with high levels of cholesterol.
4 hours
Fasting HDL
Time Frame: Baseline
High density lipoprotein that transports fat molecules in the body. Associated with carrying cholesterol to the liver for degradation.
Baseline
Post HFM HDL
Time Frame: 4 hours
High density lipoprotein that transports fat molecules in the body. Associated with carrying cholesterol to the liver for degradation.
4 hours
Fasting non-HDL
Time Frame: Baseline
Total cholesterol minus HDL, often associated with a better assessment of risk for heart disease.
Baseline
Post HFM non-HDL
Time Frame: 4 hours
Total cholesterol minus HDL, often associated with a better assessment of risk for heart disease.
4 hours
Fasting LDL/HDL ratio
Time Frame: Baseline
Assessment of risk for heart disease.
Baseline
Post HFM LDL/HDL ratio
Time Frame: 4 hours
Assessment of risk for heart disease.
4 hours
Fasting anti-inflammatory surface receptor expression
Time Frame: Baseline
CD14, CD206 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages.
Baseline
Post HFM anti-inflammatory surface receptor expression
Time Frame: 4 hours
CD14, CD206 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages.
4 hours
Fasting pro-inflammatory surface receptor expression
Time Frame: Baseline
CD16, CD86 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages.
Baseline
Post HFM pro-inflammatory surface receptor expression
Time Frame: 4 hours
CD16, CD86 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages.
4 hours
Fasting brachial artery flow-mediated dilation
Time Frame: Baseline
Dilation of brachial artery when blood flow increases in artery. Measured by non-invasive ultrasound.
Baseline
Post HFM brachial artery flow-mediated dilation
Time Frame: 5.5 hours
Dilation of brachial artery when blood flow increases in artery. Measured by non-invasive ultrasound.
5.5 hours
Fasting superficial artery flow-mediated dilation
Time Frame: Baseline
Dilation of superficial artery when blood flow increases in artery. Measured by non-invasive ultrasound.
Baseline
Post HFM superficial artery flow-mediated dilation
Time Frame: 5.5 hours
Dilation of superficial artery when blood flow increases in artery. Measured by non-invasive ultrasound.
5.5 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Robert L Franco, PhD, Virginia Commonwealth University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 17, 2019

Primary Completion (ACTUAL)

April 29, 2021

Study Completion (ACTUAL)

April 29, 2021

Study Registration Dates

First Submitted

May 17, 2019

First Submitted That Met QC Criteria

May 17, 2019

First Posted (ACTUAL)

May 22, 2019

Study Record Updates

Last Update Posted (ACTUAL)

April 13, 2022

Last Update Submitted That Met QC Criteria

April 11, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • HM20015510-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lipemia

Clinical Trials on High-fat meal

Subscribe